NCT00419042

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

A Multicenter Randomized Phase II Trial in NSCLC Stage IV et IIIB in Elderly Dependent Patients With Evaluation of the Sequence Gemcitabine First Line Followed by Erlotinib When Progression Versus Erlotinib First Line Followed by Gemcitabine When Progression.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: Groupe Francais De Pneumo-Cancerologie · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is in non small-cell lung cancer stage IV et IIIB (T4 with pleural effusion) in elderly dependent patients with evaluation of the sequence Gemcitabine first line followed by Erlotinib when progression versus Erlotinib first line followed by Gemcitabine when progression

Detailed description

A multicenter phase II trial,prospective,randomized,open,non comparative

Conditions

• Non Small Cell Lung Cancer

Interventions

Type	Name	Description
DRUG	TARCEVA	Tarceva (150 mg) is a pill you take once a day -- every day -- to help treat non-small cell lung cancer.
DRUG	Gemzar	GEMZAR by mixing it into a solution and giving it through a needle into a vein-called intravenous infusion (IV). This will take about 30 minutes

Timeline

• Start date: 2006-07-01
• Primary completion: 2006-09-01
• Completion: 2010-03-01
• First posted: 2007-01-05
• Last updated: 2013-10-01

Locations

23 sites across 1 country: France